The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire

Human Immunology

Volumn 58, Issue 1, 1997, Pages 12-20

  Sidney, John ^a   Del Guercio, Marie France ^a   Southwood, Scott ^a   Hermanson, Gary ^a   Maewal, Ajesh ^a   Appella, Ettore ^b   Sette, Alessandro ^a  

^a CYTEL CORPORATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; ENZYME SPECIFICITY; GENETIC TRANSFECTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION; ANTIGEN PRESENTATION; BINDING SITE; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY;

HLA A2 ANTIGEN; PEPTIDE;

ANTIGEN PRESENTATION; BINDING SITES; CELL LINE, TRANSFORMED; HLA-A2 ANTIGEN; HUMANS; PEPTIDES;

EID: 0031283455     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00206-1     Document Type: Article

References (26)

1. Parham P, Adams EJ, Arnett KL. The origins of HLA-A, B, C polymorphism. Immunol Rev. 143:1995;141.
2. Browning M, Kausa P. Genetic diversity of HLA-A2 Evolutionary and functional significance . Immunol Today. 17:1996;165.
3. Fernandez-Viña MA, Falco M, Sun Y, Stastny P. DNA typing for HLA class I alleles I.Subsets of HLA-A2 and of -A28 . Hum Immunol. 33:1992;163.
4. Krausa P, Brywka M, Savage D, Hui KM, Bunce M, Ngai JLF, Teo DLT, Ong YW, Barouch D, Allsop CEM, Hill AVS, McMichael AJ, Bodmer JG, Browning MJ. Genetic polymorphism within HLA-A*02 Significant allelic variation revealed in different populations . Tissue Antigens. 45:1996;223.
5. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290.
6. Rötzschke O, Falk K, Stevanovic S, Jung G, Rammensee H-G. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol. 22:1992;2453.
7. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2 1 molecules . Cell. 74:1993;929.
8. Parker KC, Bednarek MA, Hull LK, Utz U, Cunningham B, Zweerink HJ, Biddison WE, Coligan JE. Sequence motifs important for peptide binding to the human MHC class I molecule HLA-A2. J Immunol. 149:1992;3580.
9. del Guercio M-F, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol. 154:1995;685.
10. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today. 17:1996;261.
11. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In Tsuji K, Aizzaqa M, Sasazuki T (eds): HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol. 1. Tokyo, Oxford University Press, 1992.
12. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 26 Å resolution. J Mol Biol. 219:1991;277.
13. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide/MHC complexes A comparison of the conformations of five viral peptides presented by HLA-A2 . Cell. 75:1993;693.
14. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie CJ, Nakashima H, Furuichi E, Kuhara S, Sasazuki T. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol. 155:1995;4749.
15. Rivoltini L, Loftus DJ, Barracchini K, Arienti F, Mazzocchi A, Biddison WE, Salgaller ML, Appella E, Parmiani G, Marincola FM. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes Implications for peptide-based immunotherapy . J Immunol. 156:1996;3882.
16. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. Human histocompatibiltiy leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest. 100:1997;503.
17. Sette A, Sidney J, del Guercio M-F, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kubo RT. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Molec Immunol. 31:1994;813.
18. Shimizu Y, DeMars R. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol. 142:1989;3320.
19. Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM. Induction of antitumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci. 91:(USA):1994;2105.
20. Parham P, Brodsky FM. Partial purification and properties of BB7 2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28 . Hum Immunol. 3:1981;277.
21. Gorga JC, Horejsi V, Johnson DR, Raghupathy R, Strominger JL. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem. 262:1987;16087.
22. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Biegler A. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens - New tools for genetic analysis. Cell. 14:1978;9.
23. Rebai N, Malissen B. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens. 22:1983;107.
24. Greenwood F, Hunter W, Glover J. The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem J. 89:1963;114.
25. Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio M-F, Kubo RT, Chesnut RW, Sette A. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol. 45:1996;79.
26. Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol. 23:1993;425.